Literature DB >> 22271752

Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.

Wayne D Rosamond1, Patricia P Chang, Chris Baggett, Anna Johnson, Alain G Bertoni, Eyal Shahar, Anita Deswal, Gerardo Heiss, Lloyd E Chambless.   

Abstract

BACKGROUND: Population-based research on heart failure (HF) is hindered by lack of consensus on diagnostic criteria. Framingham (FRM), National Health and Nutrition Examination Survey (NHANES), Modified Boston (MBS), Gothenburg (GTH), and International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) code criteria, do not differentiate acute decompensated heart failure (ADHF) from chronic stable HF. We developed a new classification protocol for identifying ADHF in the Atherosclerosis Risk in Communities (ARIC) Study and compared it with these other schemes. METHODS AND
RESULTS: A sample of 1180 hospitalizations with a patient address in 4 study communities and eligible discharge codes were selected. After assessing whether the chart contained evidence of possible HF signs, 705 were fully abstracted. Two independent reviewers classified each case as ADHF, chronic stable HF, or no HF, using ARIC classification guidelines. Fifty-nine percent of cases met ARIC criteria for ADHF and 13.9% and 27.1% were classified as chronic stable HF or no HF, respectively. Among events classified as HF by FRM criteria, 68.4% were validated as ADHF, 9.6% as chronic stable HF, and 21.9% as no HF. However, 92.5% of hospitalizations with a primary ICD-9-CM 428 "heart failure" code were validated as ADHF. Sensitivities of comparison criteria to classify ADHF ranged from 38-95%, positive predictive values from 62-92%, and specificities from 19-96%.
CONCLUSIONS: Although comparison criteria for classifying HF were moderately sensitive in identifying ADHF, specificity varied when applied to a randomly selected set of suspected HF hospitalizations in the community.

Entities:  

Mesh:

Year:  2012        PMID: 22271752      PMCID: PMC3326579          DOI: 10.1161/CIRCHEARTFAILURE.111.963199

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  38 in total

1.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Assessing the population burden from heart failure: need for sentinel population-based surveillance systems.

Authors:  R J Goldberg; M A Konstam
Journal:  Arch Intern Med       Date:  1999-01-11

3.  Risk factors for heart failure in the general population: the study of men born in 1913.

Authors:  H Eriksson; K Svärdsudd; B Larsson; L O Ohlson; G Tibblin; L Welin; L Wilhelmsen
Journal:  Eur Heart J       Date:  1989-07       Impact factor: 29.983

4.  Incidence and aetiology of heart failure; a population-based study.

Authors:  M R Cowie; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; V Suresh; G C Sutton
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

5.  Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1995-06       Impact factor: 29.983

6.  Prevalence and mortality rate of congestive heart failure in the United States.

Authors:  D D Schocken; M I Arrieta; P E Leaverton; E A Ross
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

7.  Epidemiology of heart failure.

Authors:  W B Kannel; A J Belanger
Journal:  Am Heart J       Date:  1991-03       Impact factor: 4.749

8.  Incidence of heart failure in eastern Finland: a population-based surveillance study.

Authors:  J Remes; A Reunanen; A Aromaa; K Pyörälä
Journal:  Eur Heart J       Date:  1992-05       Impact factor: 29.983

9.  Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Authors:  K K Ho; K M Anderson; W B Kannel; W Grossman; D Levy
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

View more
  170 in total

1.  Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.

Authors:  John W McEvoy; Yuan Chen; Chiadi E Ndumele; Scott D Solomon; Vijay Nambi; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

2.  Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.

Authors:  Yuichiro Yano; Jared P Reis; Laura A Colangelo; Daichi Shimbo; Anthony J Viera; Norrina B Allen; Samuel S Gidding; Adam P Bress; Philip Greenland; Paul Muntner; Donald M Lloyd-Jones
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

3.  Early Detection of Heart Failure Using Electronic Health Records: Practical Implications for Time Before Diagnosis, Data Diversity, Data Quantity, and Data Density.

Authors:  Kenney Ng; Steven R Steinhubl; Christopher deFilippi; Sanjoy Dey; Walter F Stewart
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-11-08

4.  Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).

Authors:  Melissa C Caughey; Carla A Sueta; Sally C Stearns; Amil M Shah; Wayne D Rosamond; Patricia P Chang
Journal:  Am J Cardiol       Date:  2018-03-28       Impact factor: 2.778

5.  Mitochondrial DNA Copy Number and Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yun Soo Hong; Ryan J Longchamps; Di Zhao; Christina A Castellani; Laura R Loehr; Patricia P Chang; Kunihiro Matsushita; Megan L Grove; Eric Boerwinkle; Dan E Arking; Eliseo Guallar
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

6.  Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lucy S Witt; Jason Rotter; Sally C Stearns; Rebecca F Gottesman; Anna M Kucharska-Newton; A Richey Sharrett; Lisa M Wruck; Jan Bressler; Carla A Sueta; Patricia P Chang
Journal:  J Gen Intern Med       Date:  2018-07-20       Impact factor: 5.128

7.  Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Authors:  Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh
Journal:  Kidney Int       Date:  2017-08-31       Impact factor: 10.612

8.  Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study.

Authors:  Amil M Shah; Susan Cheng; Hicham Skali; Justina Wu; Judy R Mangion; Dalane Kitzman; Kunihiro Matsushita; Suma Konety; Kenneth R Butler; Ervin R Fox; Nakela Cook; Hanyu Ni; Josef Coresh; Thomas H Mosley; Gerardo Heiss; Aaron R Folsom; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

9.  Physical activity and cardiovascular disease in African Americans in Atherosclerosis Risk in Communities.

Authors:  Elizabeth J Bell; Pamela L Lutsey; Beverly G Windham; Aaron R Folsom
Journal:  Med Sci Sports Exerc       Date:  2013-05       Impact factor: 5.411

10.  Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.

Authors:  Yashashwi Pokharel; Wensheng Sun; Dennis T Villareal; Elizabeth Selvin; Salim S Virani; Chiadi E Ndumele; Ron C Hoogeveen; Josef Coresh; Eric Boerwinkle; Kenneth R Butler; Scott D Solomon; James S Pankow; Biykem Bozkurt; Christie M Ballantyne; Vijay Nambi
Journal:  Eur J Prev Cardiol       Date:  2016-12-12       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.